Ignite Creation Date:
2024-05-06 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03562468
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2018-05-25
Brief Title:
A Study by ChromaDex to Assess the Effects of TRU NIAGEN on Cognitive Function Mood and Sleep in Older Adults
Sponsor:
ChromaDex Inc
Organization:
ChromaDex Inc
Study Overview
Official Title:
A Randomized Double-Blind Crossover Study to Assess the Effects of Nicotinamide Riboside on Cognitive Function Mood and Sleep in Older Adult Men and Women
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The sponsor of this study is ChromaDex Inc This is a double-blind randomized crossover study to investigate the effects of 300 mgd and 1000 mgd TRU NIAGEN nicotinamide riboside compared to a placebo control on cognitive function mood and sleep in men and women over 55 years of age The trial is managed by Midwest Center for Metabolic and Cardiovascular Research
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None